Clinical trial
Construction of Key Technology and Study of the Effect Mechanism of Moxibustion in the Treatment of Diabetic Peripheral Neuropathy Based on Optimal Selection of Acupoints and Moxibustion Volume
NCT06330233 is registered in ClinicalTrials.gov with Zhejiang Chinese Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Construction of Key Technology and Study of the Effect Mechanism of Moxibustion in the Treatment of Diabetic Peripheral Neuropathy Based on Optimal Selection of Acupoints and Moxibustion Volume
- Lead sponsor
- Zhejiang Chinese Medical University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 90 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic peripheral neuropathy, moxibustion, pain, randomized controlled trial